Glyzerin Rösch (Glycerol)

Glyzerin Rösch is a glycerol‑based rectal preparation marketed in the European Union. The product contains glycerol as its sole active ingredient and is supplied in a form intended for rectal administration. It is used primarily for its lubricating and mild laxative properties, providing a non‑systemic option for local gastrointestinal support.

Glyzerin Rösch is indicated for local rectal use where a gentle, non‑irritating lubricant or mild laxative effect is desired. It may be employed in the following situations:

- Relief of occasional constipation when a gentle approach is preferred. - Preparation of the rectal area before diagnostic procedures. - Softening of hard stool to facilitate easier passage. - Adjunctive care for patients with hemorrhoidal discomfort. - Temporary relief of minor anal irritation or fissure discomfort.

Side effects of Glyzerin Rösch are generally mild and related to its local action in the rectum. Most users experience no significant adverse events, but some may notice the following:

Common: - Mild rectal irritation or burning sensation. - Temporary increase in bowel movement frequency. - Slight watery discharge after administration.

Serious: - Persistent rectal pain or ulceration. - Severe allergic reaction such as rash, itching, or swelling. - Unexplained rectal bleeding.

Before using Glyzerin Rösch, consider the following precautions to ensure safe and appropriate use:

- Verify that the product is intended for rectal use only; do not apply to other mucosal surfaces. - Avoid use in individuals with known hypersensitivity to glycerol or any excipients. - Consult a healthcare professional before use in pregnancy, lactation, or in children. - Do not use if there is active rectal bleeding, severe hemorrhoids, or anal fissures without medical advice. - Store at room temperature, protected from moisture and direct sunlight. - Keep out of reach of children and pets.

Glyzerin Rösch may interact with other rectally administered agents or systemic medications that affect bowel motility. Consider the following interaction guidance:

Avoid: - Concurrent use with other strong laxatives or stimulant agents, which may increase the risk of diarrhea. - Application together with rectal enemas containing irritant substances.

Use with caution: - Co‑administration with oral medications that have narrow therapeutic windows, as altered bowel transit could affect absorption. - Use alongside topical rectal preparations containing anesthetics, which may mask irritation. - Patients on anticoagulant therapy should monitor for any unexpected rectal bleeding.